Atlas Trials

Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT06581081 · RECRUITING

Trial details

NCT number
NCT06581081
Sponsor
Peking University People's Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed Adult ALLB-cell Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic LeukemiaRelapsed Pediatric ALL
Start date
2024-10-01
Primary completion
2027-08-31
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.